⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALKS News
Alkermes Inc. plc
Follicular Lymphoma Market Trends, Opportunities, Growth Challenges and Competitive Intelligence 2025-2035
globenewswire.com
MRK
AZN
CRSP
BGNE
NKTR
ALKS
XNNY
BMY
Alkermes to Participate in Two Upcoming Investor Conferences
businesswire.com
ALKS
Alcohol Use Disorder Market to Grow Rapidly at a 13.6% CAGR by 2034 Owing to Rising Disease Prevalence, Significant Advancements in Genetically-targeted Therapies, along with Innovative Treatments such as GLP-1 Receptor Agonists | DelveInsight
prnewswire.com
ADIL
ATAI
ALKS
ALT
MDVN
Alkermes plc Announces Increased Offer to Acquire Avadel Pharmaceuticals plc
prnewswire.com
ALKS
AVDL
Avadel Board of Directors Declares Lundbeck Proposal a “Company Superior Proposal”
globenewswire.com
AVDL
ALKS
Alkermes Response to Avadel Announcement USA - English USA - English
prnewswire.com
ALKS
Avadel Receives Unsolicited Proposal from Lundbeck
globenewswire.com
AVDL
ALKS
Alkermes Announces Positive Topline Results From Vibrance-2 Phase 2 Study of Once-Daily Alixorexton in Patients With Narcolepsy Type 2 USA - English USA - English
prnewswire.com
ALKS
Alkermes Announces Positive Topline Results From Vibrance-2 Phase 2 Study of Once-Daily Alixorexton in Patients With Narcolepsy Type 2
prnewswire.com
ALKS
Alkermes to Participate in Two Upcoming Investor Conferences
prnewswire.com
ALKS